Clinical Trial Update: Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating safety and immunogenicity of meningococcal B and ACWY vaccines in at-risk populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Meningitis
• Meningococcal Disease

Drugs mentioned

• Meningococcal ACWY vaccine
• Meningococcal B vaccine (Meningococcal B vaccine)

Snippet

Sponsor: St George's, University of London | Conditions: Hiv, Meningitis, Meningococcal | Phase 4 | Status: UNKNOWN